POS-327 BARRIERS TO ACCESSING ESSENTIAL MEDICINES FOR KIDNEY DISEASE: AN INTERNATIONAL SURVEY
Anna Francis(Children's Health Queensland Hospital and Health Service), Vivekanand Jha(The George Institute for Global Health), Muhammad Hafidz(Universiti Teknologi MARA), Sabine Karam(American University of Beirut), Udeme E. Ekrikpo(University of Uyo), T. Chen(Westmead Hospital), Nikhil Pereira-Kamath, Robert Kalyesubula(Africa Center), Eranga Wijewickrama(University of Colombo), Viviane Cálice-Silva(Universidade da Região de Joinville), Elliot Koranteng Tannor(Kwame Nkrumah University of Science and Technology), Vivek Kumar(Post Graduate Institute of Medical Education and Research), Rahul Chanchlani(McMaster Children's Hospital), M Wong(University of British Columbia), Georges Nakhoul(Cleveland Clinic)
Cited by 0
Related Papers
Worldwide access to treatment for end-stage kidney disease: a systematic review
|The Lancet|2015|2.3k
Chronic kidney disease and the global public health agenda: an international consensus
|Nature Reviews Nephrology|2024|1.1k
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Nephrology Dialysis Transplantation|2019|587